130 related articles for article (PubMed ID: 2888052)
1. Carrier assessment for mothers and sisters of isolated Duchenne dystrophy cases: the importance of serum enzyme determinations.
Hyser CL; Doherty RA; Griggs RC; Mendell JR; Polakowska R; Quirk S; Brooke MH; Fenichel GM
Neurology; 1987 Sep; 37(9):1476-80. PubMed ID: 2888052
[TBL] [Abstract][Full Text] [Related]
2. Use of serum creatine kinase, pyruvate kinase, and genetic linkage for carrier detection in Duchenne and Becker dystrophy.
Hyser CL; Griggs RC; Mendell JR; Polakowska R; Quirk S; Brooke MH; Fenichel GM; Doherty RA
Neurology; 1987 Jan; 37(1):4-10. PubMed ID: 2879259
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
Zatz M; Otto PA
Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
[TBL] [Abstract][Full Text] [Related]
4. Detection of carriers of X-linked gene for Duchenne muscular dystrophy by levels of creatine kinase and pyruvate kinase.
Falcão-Conceição DN; Gonçalves-Pimentel MM; Baptista ML; Ubatuba S
J Neurol Sci; 1983 Dec; 62(1-3):171-80. PubMed ID: 6668472
[TBL] [Abstract][Full Text] [Related]
5. Serum pyruvate kinase in different neuromuscular diseases and in carriers of muscular dystrophy.
Savonitto C; Bonadonna G; Bongiovanni LG; Duso E; De Grandis D
Ital J Neurol Sci; 1983 Dec; 4(4):417-22. PubMed ID: 6674240
[TBL] [Abstract][Full Text] [Related]
6. Carrier diagnosis of Duchenne muscular dystrophy using restriction fragment length polymorphisms.
Hejtmancik JF; Harris SG; Tsao CC; Ward PA; Caskey CT
Neurology; 1986 Dec; 36(12):1553-62. PubMed ID: 2878392
[TBL] [Abstract][Full Text] [Related]
7. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
[TBL] [Abstract][Full Text] [Related]
8. Carrier testing in families of isolated cases of duchenne muscular dystrophy. Creatine kinase activities in female relatives of mothers with normal CK activity.
Nicholson GA; Lane RJ; Gardner-Medwin D; Walton JN
J Neurol Sci; 1981 Jul; 51(1):29-42. PubMed ID: 7252519
[TBL] [Abstract][Full Text] [Related]
9. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
Passos MR; Gonzalez CH; Zatz M
Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
[TBL] [Abstract][Full Text] [Related]
10. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.
Griggs RC; Mendell JR; Brooke MH; Fenichel GM; Miller JP; Province M; Moxley RT; Huntzinger D; Vaughn A; Cohen M
Muscle Nerve; 1985 Jan; 8(1):60-7. PubMed ID: 4058458
[TBL] [Abstract][Full Text] [Related]
11. Genetic counselling in Duchenne and Becker muscular dystrophy is problematic when carrier studies give controversial results.
Kääriäinen H; Lindlöf M; Somer H; de la Chapelle A
Clin Genet; 1990 Mar; 37(3):179-87. PubMed ID: 1969777
[TBL] [Abstract][Full Text] [Related]
12. The use of concomitant serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) for carrier detection in Duchenne's muscular dystrophy through discriminant analysis.
Zatz M; Otto PA
J Neurol Sci; 1980 Sep; 47(3):411-7. PubMed ID: 7420115
[TBL] [Abstract][Full Text] [Related]
13. Prenatal diagnosis and carrier detection by DNA studies in a Duchenne muscular dystrophy family with no living affected male.
Chen JD; Denton MJ; Serravalle S; Morgan G
Aust Paediatr J; 1988 Dec; 24(6):351-3. PubMed ID: 2907402
[TBL] [Abstract][Full Text] [Related]
14. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker).
Zatz M; Shapiro LJ; Campion DS; Kaback MM; Otto PA
J Neurol Sci; 1980 Jun; 46(3):267-79. PubMed ID: 7381516
[TBL] [Abstract][Full Text] [Related]
15. Plasma pyruvate kinase and creatine kinase activity in Becker muscular dystrophy.
Aston JP; Kingston HM; Ramasamy I; Walters EG; Stansbie D
J Neurol Sci; 1984 Sep; 65(3):307-14. PubMed ID: 6491692
[TBL] [Abstract][Full Text] [Related]
16. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers.
Seay AR; Ziter FA; Wu LH; Wu JT
Neurology; 1978 Oct; 28(10):1047-50. PubMed ID: 570660
[TBL] [Abstract][Full Text] [Related]
17. Racial effect on serum creatine-kinase: implications for estimation of heterozygosity risks for females at-risk for Duchenne dystrophy.
Passos-Bueno MR; Rabbi-Bortolini E; Azevêdo E; Zatz M
Clin Chim Acta; 1989 Feb; 179(2):163-8. PubMed ID: 2920447
[No Abstract] [Full Text] [Related]
18. Carrier detection and prenatal diagnosis in X linked muscular dystrophy using restriction fragment length polymorphisms.
Lindlöf M; Kääriäinen H; Davies KE; de la Chapelle A
J Med Genet; 1986 Dec; 23(6):560-72. PubMed ID: 2879928
[TBL] [Abstract][Full Text] [Related]
19. Serum pyruvate kinase in carriers of Duochenne muscular dystrophy.
Yamuna S; Valmikinathan K; Burt D; Emery AE
Clin Chim Acta; 1977 Aug; 79(1):277-9. PubMed ID: 890959
[TBL] [Abstract][Full Text] [Related]
20. Genetic and environmental components of serum creatine kinase (CK) and pyruvate kinase (PK) in normal twins: implication for genetic risks estimates in Duchenne muscular dystrophy carriers.
Rapaport D; Colletto GM; Zatz M
Am J Med Genet; 1988 Oct; 31(2):291-8. PubMed ID: 3232697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
